Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: Relationships to fetoplacental growth at term

Early Human Development

Volumn 46, Issue 1-2, 1996, Pages 15-26

  Osorio, Marcial ^a   Torres, Jorge ^a   Moya, Fernando ^b   Pezzullo, John ^c   Salafia, Carolyn ^c,d   Baxter, Robert ^e   Schwander, Jurg ^f   Fant, Michael ^b,g  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Fetal growth; IGF binding proteins; IGFs; Placental growth

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; CHILE; CONTROLLED STUDY; FETUS GROWTH; GESTATIONAL AGE; HUMAN; MULTIPLE REGRESSION; NEWBORN; NORMAL HUMAN; NORTH AMERICA; PLACENTA WEIGHT; POPULATION RESEARCH; RADIOIMMUNOASSAY; UMBILICAL CORD BLOOD;

EID: 0030595367     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-3782(96)01737-9     Document Type: Article

References (23)

1. [1] D'Ercole, A.J., Applewhite, G.T. and Underwood, L.E. (1980): Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev. Biol., 75, 315-328.
2. [2] Han, V.K.M., D'Ercole, A.J. and Lund, P.K. (1987): Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science, 236, 193-197.
3. [3] Bennett, A., Wilson, D.M., Liu, F., Nagashima, R., Rosenfeld, R.G. and Hintz, R.L. (1983): Levels of insulin-like growth factors I and II in human cord blood. J. Clin. Endocrinol. Metab., 57, 609-612.
4. [4] Gluckman, P.D., Johnson-Barrett, J.J., Butler, J.H., Edgar, B.W. and Gunn, T.R. (1983): Studies of insulin-like growth factors I and II by specific radioligand assays in umbilical cord blood. Clin. Endocrinol., 19, 405-413.
5. [5] Ashton, I.K. and Vesey, J. (1978): Somatomedin activity in human cord plasma and relationship to birth size, insulin, growth hormone, and prolactin. Early Hum. Dev., 2, 115-122.
6. [6] Lassarre, C., Hardouin, S., Daffos, F., Forestier, F., Frankenne, F. and Binoux, M. (1991): Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr. Res., 29, 2319-2325.
7. [7] Unterman, T.G., Simmons, R.A., Glick, R.P. and Ogata, E.S. (1993): Circulating levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein in the small for gestational age fetal rat. Endocrinology, 132, 327-336.
8. [8] Fant, M., Salafia, C., Baxter, R.C., Schwander, J., Vogel, C., Pezzullo, J. and Moya, F. (1993): Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regulatory Peptides, 48, 29-39.
9. [9] D'Ercole, A.J., Wilson, D.F. and Underwood, L.E. (1980): Changes in the circulating forms of somatomedin during fetal life. J. Clin. Endocrinol. Metab., 57, 674-676.
10. [10] Drop, S.L.S., Brinkman, A., Kortleve, D.J., Groffen, Schuller, A. and Warthoff, Z. (1991): The evolution of the insulin-like growth factor binding protein family. In: Modern Concepts of Insulin-like Growth Factors, pp. 311-328. Editor: E.M. Spencer. Elsevier, New York.
11. [11] Baxter, R.C. (1991): Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr. Scand. (Suppl.), 372, 107-114.
12. [12] Shimasaki, S. and Ling, N. (1991): Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res., 3, 243-266.
13. [13] Reece, E.A., Wiznitzer, A., Le, A., Homko, C.J., Behrman, H. and Spencer, E.M. (1994): The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet. Gynecol., 84, 88-95.
14. [14] Giudice, L.C., De Zegher, F., Gargosky, S.E., Dsupin, B.A., De Las Fuentes, L., Crystal, R.A., Hintz, R.L. and Rosenfeld, R.G. (1995): Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J. Clin. Endocrinol. Metab., 80, 1548-1555.
15. [15] Juez, G., Lucero, E., Ventura-Junca, P., Tapia, J.L., Gonzales, H. and Winter, A. (1989): Estudio neonatal del crecimiento intrauterino en 11543 recien nacidos Chilenos de clase media 1978-1987. Rev. Chil. Pediatr., 60, 198-202.
16. [16] Lubchenco, L.O., Hansman, C. and Boyd, E. (1966): Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics, 37, 403-408.
17. [17] Hunter, W.M., and Greenwood, F.C. (1962): Preparation of iodine-131-labelled human growth hormone of high specific activity. Nature, 194, 495-496.
18. [18] Rechler, M.M., Podskalny, J.M. and Nissley, S.P. (1977): Characterization of the binding of multiplication stimulating activity (MSA) to a receptor for growth polypeptides in chick embryo fibroblasts. J. Biol. Chem., 252, 3898-3910.
19. [19] Fant, M.E., Nanu, L. and Word, R.A. (1992): A potential role for endothelin-1 in human placental growth: interactions with the insulin-like growth factor family of peptides. J. Clin. Endocrinol. Metab., 74, 1158-1163.
20. [20] Lee, W.H., Bowsher, R.R., Apathy, J.M., Smith, M.C. and Henry, D.P. (1991): Measurement of insulin-like growth factor-II in physiological fluids and tissues. II. Extraction and quantification in rat tissues. Endocrinology, 128, 815-822.
21. [21] Baxter, R.C., Martin, J.L. and Wood, M.H. (1987): Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J. Clin. Endocrinol. Metab., 65, 423-431.
22. [22] Schwander, J. and Mary, J.L. (1993): The RIA for IGFBP-2 in man, a meagre catch? Growth Regul., 3, 104-108.
23. [23] Bang, P., Westgren, M., Schwander, J., Blum, W.F., Rosenfeld, R.G. and Stangenberg, M. (1994): Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmunoassay in human fetal serum. Pediatr. Res., 36, 528-536.